Servier Pharmaceuticals shared on LinkedIn:
”We’re pleased to welcome Jerome Klein as Chief Strategy and Business Excellence Officer at Servier Pharmaceuticals.
With more than 20 years of experience in corporate strategy, commercial operations, and organizational transformation, Jérôme will lead strategy and Business Excellence functions, helping drive organizational effectiveness and support Servier’s continued growth.
Jérôme’s appointment reflects the continued evolution of our business and our commitment to building the leadership capabilities needed to advance our mission for patients.
Learn more about Jérôme and his new role.”
Jerome Klein, Chief Strategy and Business Excellence Officer at Servier Pharmaceuticals, also shared on LinkedIn:
”Bye bye Paris, hello Boston !
After 3 exciting years leading Corporate Strategy at Servier with a fantastic team and colleagues, let’s put this ambitious long-term vision into action!
This is a great pleasure for me to join our US affiliate and to contribute to this incredible growth trajectory we have been on in the US. Very happy to join such a talented and experienced US Leadership Team and drive together Servier Pharmaceuticals to new heights.
I feel energized by relocating to the Boston hub which is probably one of the most dynamic places for our industry.
As any relocation abroad, this also means a new and enriching family experience. Looking forward to the professional and personal adventure alongside Lucie Arboy-Klein and our boys.”
You can also read: Two Years of Progress in Grade 2 IDH-Mutant Glioma – Servier Pharmaceuticals
